Published in Cancer Weekly, April 7th, 2009
Prostate cancer, one of the most prevalent non-skin cancers in America, affects one in six men. In 2008, nearly two million Americans were being treated for prostate cancer; nearly 186,000 were newly diagnosed, and approximately 28,000 died from the disease.
Avraham Raz, professor of pathology and radiation oncology in the School of Medicine at Wayne State University and the Karmanos Cancer Institute, and his team of renowned research collaborators identified a cleaved form of galectin-3 as a marker for prostate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-04-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.